References
- Xu YG, Aylward JL, Swanson AM, Spiegelman VS, Vanness ER, Teng JM, et al. Nonmelanoma skin cancers: basal cell and squamous cell carcinomas. In: Abeloff's Clinical Oncology. Elsevier; 2020. p. 1052–1073.
- Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin D, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953. doi:https://doi.org/10.1002/ijc.31937.
- Griffin LL, Ali FR, Lear JT. Non-melanoma skin cancer. Clin Med. 2016;16(1):62–65. doi:https://doi.org/10.7861/clinmedicine.16-1-62.
- Hochheiser K, Gyorki DE, Gebhardt T. Skin colonization with beta papilloma virus drives tissue immunity and resistance to squamous cell cancer. Immunol Cell Biol. 2020;98(1):9–11. doi:https://doi.org/10.1111/imcb.12302.
- Carter ZA, Jacobson RK, Godsey T, Gloster HM. The frequency of auricular cartilage invasion by nonmelanoma skin cancer. Dermatol Surg. 2020;46(4):570–573. doi:https://doi.org/10.1097/DSS.0000000000001834.
- Sanyal T, Ghosh SK. Anti-cancer property of Lenzites betulina (L) Fr. on cervical cancer cell lines and its anti-tumor effect on HeLa-implanted mice. BioRxiv. 2019;1:540567. doi:https://doi.org/10.1101/540567.
- Salehi B, Zucca P, Sharifi-Rad M, Pezzani R, Rajabi S, Setzer WN, et al. Phytotherapeutics in cancer invasion and metastasis. Phytother Res. 2018;32(8):1425–1449. doi:https://doi.org/10.1002/ptr.6087.
- Luo C, Balsa E, Perry EA, Liang J, Tavares CD, Vazquez F, et al. H3K27me3-mediated PGC1α gene silencing promotes melanoma invasion through WNT5A and YAP. J Clin Invest. 2020;130(2):853–862. doi:https://doi.org/10.1172/JCI130038.
- Jeynes JCG, Wordingham F, Moran LJ, Curnow A, Harries TJ. Monte Carlo simulations of heat deposition during photothermal skin cancer therapy using nanoparticles. Biomolecules. 2019;9(8):343. doi:https://doi.org/10.3390/biom9080343.
- Sajadimajd S, Bahramsoltani R, Iranpanah A, Patra JK, Das G, Gouda S, et al. Advances on natural polyphenols as anticancer agents for skin cancer. Pharmacol Res. 2020;151:104584. doi:https://doi.org/10.1016/j.phrs.2019.104584.
- Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Harrison's principles of internal medicine. New York (NY): Mcgraw-Hill; 2012.
- Burtis CA, Ashwood ER, Tietz BD. Textbook of clinical chemistry and molecular diagnostics-e-book. Elsevier Health Sciences; 2012.
- Ostrow JD, Pascolo L, Brites D, Tiribelli C. Molecular basis of bilirubin-induced neurotoxicity. Trends Mol Med. 2004;10(2):65–70. doi:https://doi.org/10.1016/j.molmed.2003.12.003.
- Ye H, Xing Y, Zhang L, Zhang J, Jiang H, Ding D, et al. Bilirubin-induced neurotoxic and ototoxic effects in rat cochlear and vestibular organotypic cultures. Neurotoxicology. 2019;71:75–86. doi:https://doi.org/10.1016/j.neuro.2018.12.004.
- Schwertner HA, Vítek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis. 2008;198(1):1–11. doi:https://doi.org/10.1016/j.atherosclerosis.2008.01.001.
- Wu X, Zhou D, Song J, Sun M, Pan Y. Molecular probes for identification of UDP-glucuronosyltransferase 1 gene polymorphisms for Gilbert's syndrome diagnosis. Biomed Res. 2018;29(10):938–970. doi:https://doi.org/10.4066/biomedicalresearch.29-18-456.
- Zucker SD, Horn PS, Sherman KE. Serum bilirubin levels in the US population: gender effect and inverse correlation with colorectal cancer. Hepatology. 2004;40(4):827–835. doi:https://doi.org/10.1002/hep.1840400412.
- Claridge LC, Armstrong MJ, Booth C, Gill PS. Gilbert's syndrome. BMJ. 2011;342:d2293. doi:https://doi.org/10.1136/bmj.d2293.
- King D, Armstrong M. Overview of Gilbert's syndrome. Drug Ther Bull. 2019;57(2):27–31. doi:https://doi.org/10.1136/dtb.2018.000028.
- Sedlak TW, Saleh M, Higginson DS, Paul BD, Juluri KR, Snyder SH. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc Natl Acad Sci USA. 2009;106(13):5171–5176. doi:https://doi.org/10.1073/pnas.0813132106.
- Allahbakhshian-Farsani M, Abdian N, Ghasemi-Dehkordi P, Sadeghiani M, Saffari-Chaleshtori J, Hashemzadeh-Chaleshtori M, et al. Cytogentic analysis of human dermal fibroblasts (HDFs) in early and late passages using both karyotyping and comet assay techniques. Cytotechnology. 2014;66(5):815–822. doi:https://doi.org/10.1007/s10616-013-9630-y.
- Kaur M, Velmurugan B, Rajamanickam S, Agarwal R, Agarwal C. Gallic acid, an active constituent of grape seed extract, exhibits anti-proliferative, pro-apoptotic and anti-tumorigenic effects against prostate carcinoma xenograft growth in nude mice. Pharm Res. 2009;26(9):2133–2140. doi:https://doi.org/10.1007/s11095-009-9926-y.
- Kumi‐Diaka J, Sanderson NA, Hall A. The mediating role of caspase‐3 protease in the intracellular mechanism of genistein‐induced apoptosis in human prostatic carcinoma cell lines, DU145 and LNCaP. Biol Cell. 2000;92(8–9):595–604. doi:https://doi.org/10.1016/S0248-4900(00)01109-6.
- Buch K, Peters T, Nawroth T, Sänger M, Schmidberger H, Langguth P. Determination of cell survival after irradiation via clonogenic assay versus multiple MTT assay–a comparative study. Radiat Oncol. 2012;7(1):1. doi:https://doi.org/10.1186/1748-717X-7-1.
- Zhang Y, Li X, Hou Y, Fang N, You J, Zhou Q. Erratum: The lncRNA XIST exhibits oncogenic properties via regulation of miR-449a and Bcl-2 in human non-small cell lung cancer. Acta Pharmacol Sin. 2017;38(3):443–443. doi:https://doi.org/10.1038/aps.2017.3.
- Keshavan P, Schwemberger SJ, Smith DL, Babcock GF, Zucker SD. Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization. Int J Cancer. 2004;112(3):433–445. doi:https://doi.org/10.1002/ijc.20418.
- Ollinger R, Kogler P, Troppmair J, Hermann M, Wurm M, Drasche A, et al. Bilirubin inhibits tumor cell growth via activation of ERK. Cell Cycle. 2007;6(24):3078–3085. doi:https://doi.org/10.4161/cc.6.24.5022.
- Satari A, Amini SA, Raeisi E, Lemoigne Y, Heidarian E. Synergetic impact of combined 5-fluorouracil and rutin on apoptosis in PC3 cancer cells through the modulation of P53 gene expression. Adv Pharm Bull. 2019;9(3):462–469. doi:https://doi.org/10.15171/apb.2019.055.
- Shojaeian A, Mehri-Ghahfarrokhi A, Banitalebi-Dehkordi M. Increased in vitro migration of human umbilical cord mesenchymal stem cells toward acellular foreskin treated with bacterial derivatives of monophosphoryl lipid A or supernatant of Lactobacillus acidophilus. Hum Cell. 2020;33(1):10–22. doi:https://doi.org/10.1007/s13577-019-00308-7.
- Mollà M, Gironella M, Miquel R, Tovar V, Engel P, Biete A, et al. Relative roles of ICAM-1 and VCAM-1 in the pathogenesis of experimental radiation-induced intestinal inflammation. International Journal of Radiation Oncology, Biology, Physics. 2003;57(1):264–273. doi:https://doi.org/10.1016/S0360-3016(03)00523-6.
- Cook-Mills JM, Johnson JD, Deem TL, Ochi A, Wang L, Zheng Y. Calcium mobilization and Rac1 activation are required for VCAM-1 (vascular cell adhesion molecule-1) stimulation of NADPH oxidase activity. Biochem J. 2004;378(Pt 2):539–547. doi:https://doi.org/10.1042/BJ20030794.
- Matheny HE, Deem TL, Cook-Mills JM. Lymphocyte migration through monolayers of endothelial cell lines involves VCAM-1 signaling via endothelial cell NADPH oxidase. J Immunol. 2000;164(12):6550–6559. doi:https://doi.org/10.4049/jimmunol.164.12.6550.
- Hayashi S, Takamiya R, Yamaguchi T, Matsumoto K, Tojo SJ, Tamatani T, et al. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ Res. 1999;85(8):663–671. doi:https://doi.org/10.1161/01.res.85.8.663.
- Clark J, Foresti R, Green C, Motterlini R. Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem J. 2000;348(3):615–659. doi:https://doi.org/10.1042/bj3480615.
- Keshavan P, Deem TL, Schwemberger SJ, Babcock GF, Cook-Mills JM, Zucker SD. Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration. J Immunol. 2005;174(6):3709–3718. doi:https://doi.org/10.4049/jimmunol.174.6.3709.
- Palmela I, Sasaki H, Cardoso FL, Moutinho M, Kim KS, Brites D, Brito MA. Time-dependent dual effects of high levels of unconjugated bilirubin on the human blood-brain barrier lining. Front Cell Neurosci. 2012;6:22. doi:https://doi.org/10.3389/fncel.2012.00022.
- Arias‐Mejias SM, Warda KY, Quattrocchi E, Alonso‐Quinones H, Sominidi‐Damodaran S, Meves A. The role of integrins in melanoma: a review. Int J Dermatol. 2020;59(5):525–534. doi:https://doi.org/10.1111/ijd.14850.
- Klemke M, Weschenfelder T, Konstandin MH, Samstag Y. High affinity interaction of integrin alpha4beta1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers. J Cell Physiol. 2007;212(2):368–374. doi:https://doi.org/10.1002/jcp.21029.
- Yao Z, Lin Z, Wang T, Tian D, Zou X, Gao Y, Yin D. Using molecular docking-based binding energy to predict toxicity of binary mixture with different binding sites. Chemosphere. 2013;92(9):1169–1176. doi:https://doi.org/10.1016/j.chemosphere.2013.01.081.